State Street
BHVN

State Street’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

State Street’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,763,828
Closed -$267M – 5008
2022
Q3 		$267M Buy
1,763,828
+18,782
+1% +$2.78M 0.02% 634
2022
Q2 		$254M Buy
1,745,046
+89,212
+5% +$11.4M 0.02% 656
2022
Q1 		$196M Buy
1,655,834
+8,140
+0.5% +$1.02M 0.01% 844
2021
Q4 		$227M Buy
1,647,694
+162,764
+11% +$20.7M 0.01% 795
2021
Q3 		$206M Buy
1,484,930
+4,363
+0.3% +$545K 0.01% 820
2021
Q2 		$144M Sell
1,480,567
-54,177
-4% -$4.4M 0.01% 1045
2021
Q1 		$105M Sell
1,534,744
-137,205
-8% -$11.1M 0.01% 1197
2020
Q4 		$143M Sell
1,671,949
-101,223
-6% -$8.58M 0.01% 909
2020
Q3 		$115M Buy
1,773,172
+2,463
+0.1% +$161K 0.01% 891
2020
Q2 		$129M Sell
1,770,709
-205,232
-10% -$10.9M 0.01% 822
2020
Q1 		$67.2M Buy
1,975,941
+64,533
+3% +$2.95M 0.01% 1067
2019
Q4 		$104M Sell
1,911,408
-133,535
-7% -$6.61M 0.01% 1024
2019
Q3 		$85.3M Buy
2,044,943
+456,986
+29% +$19.3M 0.01% 1101
2019
Q2 		$69.5M Buy
1,587,957
+248,909
+19% +$14M 0.01% 1265
2019
Q1 		$68.9M Buy
1,339,048
+327,534
+32% +$14.2M 0.01% 1258
2018
Q4 		$37.4M Sell
1,011,514
-310,841
-24% -$11.2M ﹤0.01% 1542
2018
Q3 		$49.7M Sell
1,322,355
-168,597
-11% -$6.2M ﹤0.01% 1541
2018
Q2 		$58.9M Buy
1,490,952
+982,149
+193% +$31.2M ﹤0.01% 1378
2018
Q1 		$13.1M Buy
508,803
+329,986
+185% +$9.87M ﹤0.01% 2332
2017
Q4 		$4.82M Buy
178,817
+18,042
+11% +$497K ﹤0.01% 2810
2017
Q3 		$6.01M Buy
160,775
+43,563
+37% +$1.32M ﹤0.01% 2703
2017
Q2 		$2.93M Buy
+117,212
New +$2.7M ﹤0.01% 2979

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

State Street's BHVN Position: Q4 2022 in Review

State Street sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 1,763,828 shares — an estimated $267M sold.

State Street first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $267M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • State Street reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • State Street sold 1,763,828 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $267M.
  • State Street first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • State Street's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $267M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.